NorthStrive eyes emerging GLP-1 opportunity: muscle preservation

New patent filings target one of weight loss medicine’s biggest challenges: keeping muscle while shedding pounds. By securing patent claims across both peptide constructs (EL-22) and bioengineered microorganisms (EL-32), is the company trying to build an ironclad monopoly on the entire muscle-preservation side of the weight-loss industry? That may be a provocative way of framing […] The post NorthStrive eyes emerging GLP-1 opportunity: muscle preservation appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.